AGP Picks
View all

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on July 10, 2026

HUBG Shareholder Alert: Hub Group, Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm
WGS Deadline Alert: The Gross Law Firm Reminds GeneDx Holdings Corp. (WGS) Investors of Securities Class Action Deadline on August 3, 2026
The Gross Law Firm Reminds Helen of Troy Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 3, 2026 - HELE
Sprout Social Named as a Visionary in the 2026 Gartner® Magic Quadrant™ for Social Media Management and Listening
MSFT Investors Have Opportunity to Lead Microsoft Corporation Securities Fraud Lawsuit with the Schall Law Firm
Palisade Bio to Participate in the Leerink Partners Therapeutics Forum
Beamr's ML-Safe Video Data Technology Now Available on the RTMaps AI Store
TryHard Holdings Limited to Hold Extraordinary General Meeting on July 21, 2026
Study Results of Orelabrutinib in Patients with SLE Published in the Journal of Autoimmunity
ParaZero Accelerates Active Counter-FPV Protection for Vehicles and High-Value Assets Amid Escalating Battlefield Threats
Sky Quarry Taps 35-Year Refining Veteran to Run Foreland as Nevada's Only Refinery Enters Production
Z Investors Have Opportunity to Lead Zillow Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
A Past-Producing Nevada Tungsten Mine Just Lit Up in Soil — and Western Star Is Already Expanding the Hunt
Aura Announces Preliminary Q2 2026 and H1 2026 Production Results
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Global Technology Virtual Investor Presentations Now Available for On-Demand Viewing
Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
Communiqué de presse : Sarclisa Escena de Sanofi, la formulation sous-cutanée du Sarclisa, approuvé aux États-Unis comme premier traitement anticancéreux administré via un injecteur portable
Important Notice to Long-Term Shareholders of First Solar, Inc. (NSADAQ: FSLR); Insulet Corporation (NASDAQ: PODD); Photronics, Inc. (NASDAQ: PLAB); and Via Transportation, Inc. (NYSE: VIA): Grabar Law Office is Investigating Claims on Your Behalf
Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.